A man aged 49 was admitted to hospital on 15 October 1964 with a two-day history of increasingly severe abdominal pain, vomiting, and diarrhoea. He had been admitted to hospital five years, six months, and two months previously on account of abdominal pain,
[WITH SPECIAL PLATE] Brit. med. J., 1965, 2, 1408-1409 Over the past several years we have reported on the favourable use of D-penicillarninel (D-pen.) in 14 patients with cystinuria whose disease could not be controlled by the conventional therapeutic regimen of forced fluids, alkali, and restriction of dietary methionine (Lotz and Potts 1964; Lotz et al., 1965a; Bartter et al., 1965) . Similar reports by others have also appeared (Crawhall et al., 1963 (Crawhall et al., , 1964 . In this report we wish to offer recent evidence of significant stone dissolution that we have now observed in four of our patients with refractory cystinuria after the addition of D-pen. to the conventional therapeutic programme. Preliminary mention has been made elsewhere of two of these cases (Lotz et al., 1965c) .
Patients Studied
All patients had cystinuria documented by stone analysis and urinary amino-acid studies. Disease had progressed in all despite adherence to fluid and alkali therapy. In Cases 1, 3, and 4 even the most strict adherence to fluid and alkali therapy, together with restriction of dietary methionine, did not prevent growth of stones. Because these patients were judged refractory to conventional management they were referred to us for further investigation and therapy. Brief clinical histories are as follows.
Case 1.-An 1 8-year-old girl had had three nephrolithotomies for cystine calculi recurring despite good adherence to conventional therapy. She was admitted to hospital in June 1964 with large bilateral renal stones (Special Plate, Fig. 1 A) (Lotz et al., 1956b) . Pyridoxine, 50 mg /day, is added to counteract any possible anti-vitamin activity of D-pen. (Jaffe et al., 1964 achieved simply by stopping therapy until symptoms subsideusually in four to five days-and then resuming therapy gradually with increasing doses over several weeks. We have used n-pen. successfully now in two patients with welldocumented histories of penicillin allergy.
Previously it was our belief that D-pen. would be effective only in preventing de novo stone formation or progression of stones already formed. Therefore patients with calculi and pyelonephritis-a complication we not infrequently encounterwere rendered stone-free surgically in order to maximize chances for eradicating infection with selected antibiotics. Our success in dissolving stones in each of these four patients has led us now to be more conservative in recommending operation to patients with nephrolithiasis complicated by pyelonephritis.
So far we have not encountered any patient whose stones proved refractory to dissolution when D-pen. was added to the conventional programme.
Over the last two years five of our patients have decided, quite against our advice, to omit fluids, alkali, and methionine restriction and to continue only on D-pen. All have remained stone-free.
Because n-pen. is thought to suppress cystine most successfully in an alkaline urine we have been hesitant previously to acidify the urine of patients infected with Proteus vulgaris or patients in whom long-term suppressive therapy with Mandelamine was indicated. Our experience in Case 2 indicates that high-acidity of the urine does not interfere with the action of n-pen. Our plan with this patient is to dissolve the stones completely and then attempt a cure of pyelonephritis with appropriate antibiotics.
Summary
Significant stone dissolution occurred in four patients with cystine calculi when D-penicillamine was added to a previously ineffective conventional therapeutic programme of forced fluids, alkali, and in three cases methionine restriction.
Elective surgery for refractory nephrolithiasis complicated by pyelonephritis should be deferred until a reasonable trial has been made to effect stone dissolution with D-penicillamine.
D-Penicillamine is a highly effective therapeutic agent in cystinuria even when used alone in the absence of the conventional programme.
Sporadic cases have been reported from time to time of nonspecific ulceration of the small intestine presenting as intestinal obstruction, perforation, or haemorrhage. Recently it has become recognized that a stenosing ulcer of the small intestine may develop as a rare complication of medication with entericcoated diuretic and potassium chloride tablets.
We report six further cases. All our patients had been taking Hydrosaluric-K (enteric-coated hydrochlorothiazide with potassium chloride). One patient had taken only two tablets. We think it important that the condition be recognized as a cause of intestinal obstruction and perforation in patients taking these preparations. If the symptoms are recognized early enough improvement may follow cessation of treatment.
Case 1 A man aged 54 was admitted to hospital on 25 May 1964 with a 12-hour history of central abdominal colicky pain and vomiting. For two months he had experienced attacks of abdominal pain, usually occurring one hour after meals. He had been under treatment for malignant hypertension for five years, and had suffered a coronary thrombosis seven months previously. Gastrografin x-ray studies of the small intestine supported a diagnosis of small-intestine obstruction, and laparot6my was advised. At operation on 27 May distended small intestine was traced down to a stricture in the distal ileum. The bowel was collapsed beyond this point. The stricture had the appearance of a smooth ring of narrowing 1-2 mm. wide in the wall of the ileum, and causing almost complete occlusion of the lumen. There was no abnormality in the mesentery, and normal pulsation was observed in the vessels locally supplying the intestine. The stricture was thought to be benign, and, in view of the anaesthetic risk involved, the operation was limited to an enteroanastomosis bypassing the stricture. The patient has had no further attacks of abdominal pain since his discharge from hospital, and has started light work.
Since the diagnosis of malignant hypertension in 1960 this patient has been treated mainly with Inversine (mecamylamine) and Saluric (chlorothiazide). The Saluric was discontinued in favour of Hydrosaluric-K in 1962, and he had been taking two tablets a day, three days a week. He had also been given Darenthin (bretylium tosylate), Serpasil (reserpine), guanethidine, pyridostigmine, and neostigmine for short periods.
